Literature DB >> 2762136

Nucleotide sequence of human enteric adenovirus type 41 hexon-associated protein VIII precursor (pVIII) including the early region E3 promoter.

N Pieniazek1, J Velarde, D Pieniazek, R B Luftig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762136      PMCID: PMC318137          DOI: 10.1093/nar/17.13.5398

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  6 in total

1.  Physicochemical properties of the DNAs of the fastidious adenovirus species 40 and 41.

Authors:  A E van Loon; T H Rozijn; J C de Jong; J S Sussenbach
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

2.  Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2.

Authors:  C Signäs; G Akusjärvi; U Pettersson
Journal:  Gene       Date:  1986       Impact factor: 3.688

3.  Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome.

Authors:  J Hérissé; G Courtois; F Galibert
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

4.  Determination of nucleotide sequences in DNA.

Authors:  F Sanger
Journal:  Science       Date:  1981-12-11       Impact factor: 47.728

5.  DNA sequence of the early E3 transcription unit of adenovirus 5.

Authors:  C Cladaras; W S Wold
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

6.  The genes encoding the DNA binding protein and the 23K protease of adenovirus types 40 and 41.

Authors:  H L Vos; F M van der Lee; A M Reemst; A E van Loon; J S Sussenbach
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

  6 in total
  1 in total

1.  Nucleotide sequence of the region coding for 100K and 33K proteins of human enteric adenovirus type 41 (Tak).

Authors:  S B Slemenda; N J Pieniazek; J Velarde; D Pieniazek; R B Luftig
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.